AAAAAA
Results: 1-25/31
Authors:
DOLAN ME
FRYDMAN B
THOMPSON CB
DIAMOND AM
GARBIRAS BJ
SAFA AR
BECK WT
MARTON LJ
Citation: Me. Dolan et al., EFFECTS OF 1,2-NAPHTHOQUINONES ON HUMAN TUMOR-CELL GROWTH AND LACK OFCROSS-RESISTANCE WITH OTHER ANTICANCER AGENTS, Anti-cancer drugs, 9(5), 1998, pp. 437-448
EFFECT OF MODULATORS ON THE ATPASE ACTIVITY AND VANADATE NUCLEOTIDE TRAPPING OF HUMAN P-GLYCOPROTEIN
Authors:
SHEPARD RL
WINTER MA
HSAIO SC
PEARCE HL
BECK WT
DANTZIG AH
Citation: Rl. Shepard et al., EFFECT OF MODULATORS ON THE ATPASE ACTIVITY AND VANADATE NUCLEOTIDE TRAPPING OF HUMAN P-GLYCOPROTEIN, Biochemical pharmacology, 56(6), 1998, pp. 719-727
Authors:
MO YY
BECK WT
Citation: Yy. Mo et Wt. Beck, HETEROGENEOUS EXPRESSION OF DNA TOPOISOMERASE II-ALPHA ISOFORMS IN TUMOR-CELL LINES, Oncology research, 9(4), 1997, pp. 193-204
Authors:
BECK WT
GROGAN TM
Citation: Wt. Beck et Tm. Grogan, METHODS TO DETECT P-GLYCOPROTEIN AND IMPLICATIONS FOR OTHER DRUG RESISTANCE-ASSOCIATED PROTEINS, Leukemia, 11(7), 1997, pp. 1107-1109
Authors:
SCHELTEMA JMW
ROMIJN JC
VANSTEENBRUGGE GJ
BECK WT
SCHRODER FH
MICKISCH GH
Citation: Jmw. Scheltema et al., DECREASED LEVELS OF TOPOISOMERASE II-ALPHA IN HUMAN RENAL-CELL CARCINOMA LINES RESISTANT TO ETOPOSIDE, Journal of cancer research and clinical oncology, 123(10), 1997, pp. 546-554
Authors:
MO YY
WANG QJ
BECK WT
Citation: Yy. Mo et al., DOWN-REGULATION OF TOPOISOMERASE II-ALPHA IN CEM CELLS SELECTED FOR MERBARONE RESISTANCE IS ASSOCIATED WITH REDUCED EXPRESSION OF SP3, Cancer research, 57(22), 1997, pp. 5004-5008
Authors:
HOFMANN J
UTZ I
SPITALER M
HOFER S
RYBCZYNSKA M
BECK WT
HERRMANN DBJ
GRUNICKE H
Citation: J. Hofmann et al., RESISTANCE TO THE NEW ANTICANCER PHOSPHOLIPID ILMOFOSINE (BM-41,440), British Journal of Cancer, 76(7), 1997, pp. 862-869
Authors:
NITISS JL
BECK WT
Citation: Jl. Nitiss et Wt. Beck, ANTITOPOISOMERASE DRUG-ACTION AND RESISTANCE, European journal of cancer, 32A(6), 1996, pp. 958-966
Authors:
BECK WT
Citation: Wt. Beck, UNANSWERED QUESTIONS ABOUT MULTIDRUG-RESISTANCE, Cytotechnology, 19(3), 1996, pp. 177-179
Authors:
KUTTESCH JF
PARHAM DM
LUO XL
MEYER WH
BOWMAN L
SHAPIRO DN
PAPPO AS
CRIST WM
BECK WT
HOUGHTON PJ
Citation: Jf. Kuttesch et al., P-GLYCOPROTEIN EXPRESSION AT DIAGNOSIS MAY NOT BE A PRIMARY MECHANISMOF THERAPEUTIC FAILURE IN CHILDHOOD RHABDOMYOSARCOMA, Journal of clinical oncology, 14(3), 1996, pp. 886-900
Authors:
BECK WT
DANKS MK
WOLVERTON JS
Citation: Wt. Beck et al., FINDING THE DRUG-RESISTANT TUMOR-CELL BY MOLECULAR AND CELLULAR-ASSAYS - THE ALTERED TOPOISOMERASE PARADIGM - ASSAYS FOR DRUG-RESISTANCE, Onkologie, 19, 1996, pp. 14-18
Authors:
SCHUETZ EG
BECK WT
SCHUETZ JD
Citation: Eg. Schuetz et al., MODULATORS AND SUBSTRATES OF P-GLYCOPROTEIN AND CYTOCHROME P4503A COORDINATELY UP-REGULATE THESE PROTEINS IN HUMAN COLON-CARCINOMA CELLS, Molecular pharmacology, 49(2), 1996, pp. 311-318
Authors:
BECK WT
GROGAN TM
WILLMAN CL
CORDONCARDO C
PARHAM DM
KUTTESCH JF
ANDREEFF M
BATES SE
BERARD CW
BOYETT JM
BROPHY NA
BROXTERMAN HJ
CHAN HSL
DALTON WS
DIETEL M
FOJO AT
GASCOYNE RD
HEAD D
HOUGHTON PJ
SRIVASTAVA DK
LEHNERT M
LEITH CP
PAIETTA E
PAVELIC ZP
RIMSZA L
RONINSON IB
SIKIC BI
TWENTYMAN PR
WARNKE R
WEINSTEIN R
Citation: Wt. Beck et al., METHODS TO DETECT P-GLYCOPROTEIN-ASSOCIATED MULTIDRUG-RESISTANCE IN PATIENTS TUMORS - CONSENSUS RECOMMENDATIONS, Cancer research, 56(13), 1996, pp. 3010-3020
Authors:
KUSUMOTO H
RODGERS QE
BOEGE F
RAIMONDI SC
BECK WT
Citation: H. Kusumoto et al., CHARACTERIZATION OF NOVEL HUMAN LEUKEMIC-CELL LINES SELECTED FOR RESISTANCE TO MERBARONE, A CATALYTIC INHIBITOR OF DNA TOPOISOMERASE-II, Cancer research, 56(11), 1996, pp. 2573-2583
Authors:
BECK WT
Citation: Wt. Beck, CIRCUMVENTION OF MULTIDRUG-RESISTANCE WITH ANTI-P-GLYCOPROTEIN ANTIBODIES - CLINICAL POTENTIAL OR EXPERIMENTAL ARTIFACT, Journal of the National Cancer Institute, 87(2), 1995, pp. 73-75
Authors:
BECK WT
Citation: Wt. Beck, CIRCUMVENTION OF MULTIDRUG-RESISTANCE WITH ANTI-P-GLYCOPROTEIN ANTIBODIES - CLINICAL POTENTIAL OR EXPERIMENTAL ARTIFACT - RESPONSE, Journal of the National Cancer Institute, 87(11), 1995, pp. 845-846
Authors:
CHEN M
BECK WT
Citation: M. Chen et Wt. Beck, DNA TOPOISOMERASE-II EXPRESSION, STABILITY, AND PHOSPHORYLATION IN 2 VM-26-RESISTANT HUMAN LEUKEMIC CEM SUBLINES, Oncology research, 7(2), 1995, pp. 103-111
Authors:
HASHIMOTO S
DANKS MK
CHATTERJEE S
BECK WT
BERGER NA
Citation: S. Hashimoto et al., A NOVEL POINT MUTATION IN THE 3'-PLANKING REGION OF THE DNA-BINDING DOMAIN OF TOPOISOMERASE-II-ALPHA ASSOCIATED WITH ACQUIRED-RESISTANCE TOTOPOISOMERASE-II ACTIVE AGENTS, Oncology research, 7(1), 1995, pp. 21-29
Authors:
BAKER SD
WADKINS RM
STEWART CF
BECK WT
DANKS MK
Citation: Sd. Baker et al., CELL-CYCLE ANALYSIS OF AMOUNT AND DISTRIBUTION OF NUCLEAR-DNA TOPOISOMERASE-I AS DETERMINED BY FLUORESCENCE DIGITAL IMAGING MICROSCOPY, Cytometry, 19(2), 1995, pp. 134-145
Authors:
BHAT UG
WINTER MA
PEARCE HL
BECK WT
Citation: Ug. Bhat et al., A STRUCTURE-FUNCTION RELATIONSHIP AMONG RESERPINE AND YOHIMBINE ANALOGS IN THEIR ABILITY TO INCREASE EXPRESSION OF MDR1 AND P-GLYCOPROTEIN IN A HUMAN COLON-CARCINOMA CELL-LINE, Molecular pharmacology, 48(4), 1995, pp. 682-689
Authors:
CHEN M
BECK WT
Citation: M. Chen et Wt. Beck, DIFFERENCES IN INHIBITION OF CHROMOSOME SEPARATION AND G(2) ARREST BYDNA TOPOISOMERASE-II INHIBITORS MERBARONE AND VM-26, Cancer research, 55(7), 1995, pp. 1509-1516
Authors:
KUMAGAI M
MANABE A
COUSTANSMITH E
BLAKLEY RL
BECK WT
SANTANA VM
BEHM FG
RAIMONDI SC
CAMPANA D
Citation: M. Kumagai et al., USE OF STROMA-SUPPORTED CULTURES OF LEUKEMIC-CELLS TO ASSESS ANTILEUKEMIC DRUGS .2. POTENT CYTOTOXICITY OF 2-CHLORO-DEOXYADENOSINE IN ACUTELYMPHOBLASTIC-LEUKEMIA, Leukemia, 8(7), 1994, pp. 1116-1123
Authors:
BECK WT
KIM R
CHEN M
Citation: Wt. Beck et al., NOVEL ACTIONS OF INHIBITORS OF DNA TOPOISOMERASE-II IN DRUG-RESISTANTTUMOR-CELLS, Cancer chemotherapy and pharmacology, 34, 1994, pp. 190000014-190000018
Authors:
MARIANI M
CAPOLONGO L
SUARATO A
BARGIOTTI A
MONGELLI N
GRANDI M
BECK WT
Citation: M. Mariani et al., GROWTH-INHIBITORY PROPERTIES OF NOVEL ANTHRACYCLINES IN HUMAN LEUKEMIC-CELL LINES EXPRESSING EITHER PGP-MDR OR AT-MDR, Investigational new drugs, 12(2), 1994, pp. 93-97
Authors:
KIM RS
BECK WT
Citation: Rs. Kim et Wt. Beck, DIFFERENCES BETWEEN DRUG-SENSITIVE AND DRUG-RESISTANT HUMAN LEUKEMIC CEM CELLS IN C-JUN EXPRESSION, AP-1 DNA-BINDING ACTIVITY, AND FORMATION OF JUN FOS FAMILY DIMERS, AND THEIR ASSOCIATION WITH INTERNUCLEOSOMAL DNA LADDERS AFTER TREATMENT WITH VM-26/, Cancer research, 54(18), 1994, pp. 4958-4966